[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fBrK5YvKhMP4RezEjnh22fB9uJS0TNK3zbRhN1HMXagg":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":47,"rows":54},"Western Sydney Local Health District",[4],34,false,16,0,16534,3,28,[14,16,18,20,22,25,27,29],{"name":15,"count":11},"Colon Adenoma",{"name":17,"count":11},"Polyps",{"name":19,"count":11},"Kidney Transplant Rejection",{"name":21,"count":11},"Endoscopic Mucosal Resection",{"name":23,"count":24},"Colon Polyp",2,{"name":26,"count":24},"Ventricular Tachycardia",{"name":28,"count":24},"Colonic Adenoma",{"name":30,"count":24},"Transplant Complication",[32,37,42],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT05524077","Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia","2026-06-30","Anti-arrhythmic Drugs",{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT05509153","A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers","2026-11-01","NAC",{"nctId":43,"briefTitle":44,"date":45,"intervention":46},"NCT07445334","Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes","2027-09-01","Medical therapy: Anti-arrhythmic drugs",[48,49,50,51,52,53],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[55,79,108,133,159,187,205],{"intervention":41,"totalTrials":56,"cells":57},1,{"EARLY_PHASE1":58,"PHASE1":60,"PHASE2":62,"PHASE3":73,"PHASE4":75,"NA":77},{"trials":59,"activeCount":9},[],{"trials":61,"activeCount":9},[],{"trials":63,"activeCount":56,"soonestReadout":40},[64],{"nctId":38,"briefTitle":39,"status":65,"phases":66,"primaryCompletion":40,"completion":67,"start":68,"enrollment":69,"conditions":70,"interventions":72},"RECRUITING",[50],"2027-05-01","2024-06-01",160,[71],"Huntington Disease",[41],{"trials":74,"activeCount":9},[],{"trials":76,"activeCount":9},[],{"trials":78,"activeCount":9},[],{"intervention":36,"totalTrials":56,"cells":80},{"EARLY_PHASE1":81,"PHASE1":83,"PHASE2":85,"PHASE3":87,"PHASE4":89,"NA":91},{"trials":82,"activeCount":9},[],{"trials":84,"activeCount":9},[],{"trials":86,"activeCount":9},[],{"trials":88,"activeCount":9},[],{"trials":90,"activeCount":9},[],{"trials":92,"activeCount":56,"soonestReadout":35},[93],{"nctId":33,"briefTitle":34,"status":94,"phases":95,"primaryCompletion":35,"completion":35,"start":96,"enrollment":97,"conditions":98,"interventions":107},"ACTIVE_NOT_RECRUITING",[53],"2020-07-08",162,[99,26,100,101,102,103,104,105,106],"Heart Disease Structural Disorder","Cardiomyopathy, Dilated","Sarcoidosis","Cardiomyopathy, Hypertrophic","Cardiomyopathy Ischemic","Cardiomyopathy, Familial","Arrhythmogenic Right Ventricular Cardiomyopathy 1","Arrhythmogenic Left Ventricular Cardiomyopathy",[36],{"intervention":46,"totalTrials":56,"cells":109},{"EARLY_PHASE1":110,"PHASE1":112,"PHASE2":114,"PHASE3":116,"PHASE4":118,"NA":120},{"trials":111,"activeCount":9},[],{"trials":113,"activeCount":9},[],{"trials":115,"activeCount":9},[],{"trials":117,"activeCount":9},[],{"trials":119,"activeCount":9},[],{"trials":121,"activeCount":56,"soonestReadout":45},[122],{"nctId":43,"briefTitle":44,"status":123,"phases":124,"primaryCompletion":45,"completion":125,"start":126,"enrollment":127,"conditions":128,"interventions":132},"NOT_YET_RECRUITING",[53],"2028-03-01","2026-03-01",40,[129,130,131],"Premature Ventricular Complexes","Premature Ventricular Contraction (PVC)","Premature Ventricular Beats",[46],{"intervention":134,"totalTrials":56,"cells":135},"Metformin",{"EARLY_PHASE1":136,"PHASE1":138,"PHASE2":140,"PHASE3":153,"PHASE4":155,"NA":157},{"trials":137,"activeCount":9},[],{"trials":139,"activeCount":9},[],{"trials":141,"activeCount":9},[142],{"nctId":143,"briefTitle":144,"status":145,"phases":146,"primaryCompletion":147,"completion":147,"start":148,"enrollment":12,"conditions":149,"interventions":152},"NCT01077479","Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic Syndrome","COMPLETED",[50],"2013-06","2010-02",[150,151],"Metabolic Syndrome","Hypercholesterolemia",[134],{"trials":154,"activeCount":9},[],{"trials":156,"activeCount":9},[],{"trials":158,"activeCount":9},[],{"intervention":160,"totalTrials":56,"cells":161},"Cephalexin",{"EARLY_PHASE1":162,"PHASE1":164,"PHASE2":166,"PHASE3":181,"PHASE4":183,"NA":185},{"trials":163,"activeCount":9},[],{"trials":165,"activeCount":9},[],{"trials":167,"activeCount":9},[168],{"nctId":169,"briefTitle":170,"status":171,"phases":172,"primaryCompletion":173,"completion":174,"start":175,"enrollment":176,"conditions":177,"interventions":179},"NCT05664568","The BLAST- 1 Trial - Cephalexin+Amoxicillin-clavulanate for Tuberculosis","UNKNOWN",[50],"2024-07","2024-12","2023-03-15",30,[178],"Tuberculosis, Pulmonary",[160,180],"Amoxicillin-Clavulanate 500 Mg-125 Mg Oral",{"trials":182,"activeCount":9},[],{"trials":184,"activeCount":9},[],{"trials":186,"activeCount":9},[],{"intervention":180,"totalTrials":56,"cells":188},{"EARLY_PHASE1":189,"PHASE1":191,"PHASE2":193,"PHASE3":199,"PHASE4":201,"NA":203},{"trials":190,"activeCount":9},[],{"trials":192,"activeCount":9},[],{"trials":194,"activeCount":9},[195],{"nctId":169,"briefTitle":170,"status":171,"phases":196,"primaryCompletion":173,"completion":174,"start":175,"enrollment":176,"conditions":197,"interventions":198},[50],[178],[160,180],{"trials":200,"activeCount":9},[],{"trials":202,"activeCount":9},[],{"trials":204,"activeCount":9},[],{"intervention":206,"totalTrials":56,"cells":207},"Tamoxifen",{"EARLY_PHASE1":208,"PHASE1":210,"PHASE2":212,"PHASE3":214,"PHASE4":216,"NA":218},{"trials":209,"activeCount":9},[],{"trials":211,"activeCount":9},[],{"trials":213,"activeCount":9},[],{"trials":215,"activeCount":9},[],{"trials":217,"activeCount":9},[],{"trials":219,"activeCount":9},[220],{"nctId":221,"briefTitle":222,"status":145,"phases":223,"primaryCompletion":224,"completion":225,"start":226,"enrollment":227,"conditions":228,"interventions":231},"NCT01075802","Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms",[53],"2012-10","2012-12","2010-03",121,[229,230],"Breast Cancer","CYP2D6 Polymorphism",[206]]